Zimmer Biomet Reports Solid Q4, Beats Estimates

Warsaw, Ind. – Zimmer Biomet Holdings Inc. (ZBH) announced net income of $239.4 million for the fourth quarter, exceeding Wall Street expectations. Earnings per share stood at $1.20, while adjusted earnings reached $2.31 per share. Revenue of $2.02 billion also surpassed analysts' forecasts of $2.01 billion.

For the full year, Zimmer Biomet reported profit of $903.8 million ($4.43 per share) on revenue of $7.68 billion. The company projects full-year earnings in 2023 to range from $8.15 to $8.35 per share.